BioReliance Corporation — FDA Facility Profile

FEI 1122041

BioReliance Corporation is an FDA-inspected facility (FEI 1122041) located in Rockville, MD, US. RegDataLab tracks 11 FDA inspections and 1 compliance action at this facility.

Reviewing BioReliance Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check BioReliance Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Jan 29, 2026: Voluntary Action Indicated (VAI)
Inspections on record
11 (8 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Jan 5, 2009

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 11 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 29, 2026Voluntary Action Indicated (VAI)Study director: follow study protocol (21 CFR 58.33(a))
Study director: unforeseen circumstances (21 CFR 58.33(c))
Nov 22, 2024Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Aug 4, 2023No Action Indicated (NAI)No citations listed
Jul 13, 2018Voluntary Action Indicated (VAI)No citations listed
Jan 11, 2016No Action Indicated (NAI)No citations listed
May 14, 2014Voluntary Action Indicated (VAI)No citations listed
Aug 29, 2013Voluntary Action Indicated (VAI)No citations listed
Jul 3, 2012Voluntary Action Indicated (VAI)input/output verification (21 CFR 211.68(b))
Following/documenting laboratory controls (21 CFR 211.160(a))
Deviations from laboratory control requirements (21 CFR 211.160(a))
Data secured in course of each test (21 CFR 211.194(a)(4))
Oct 28, 2010Voluntary Action Indicated (VAI)No citations listed
Mar 17, 2010No Action Indicated (NAI)No citations listed

Facility details

Company
BioReliance Corporation
Location
Rockville, MD (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.